Evidence map›Paper›PMID 31102270›Full record

ArticleThe British journal of dermatology2019

Utilization patterns and performance of commercial myositis autoantibody panels in routine clinical practice.

P C Gandiga, J Zhang, S Sangani, P Thomas, V P Werth, M D George

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The British journal of dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

P C GandigaDivision of Rheumatology, University of Pennsylvania, Philadelphia, PA, U.S.A.ORCID 0000-0003-1635-8974
J ZhangDepartment of Internal Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A.
S SanganiDivision of Rheumatology, University of Pennsylvania, Philadelphia, PA, U.S.A.
P ThomasDivision of Rheumatology, University of Pennsylvania, Philadelphia, PA, U.S.A.
V P WerthDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA, U.S.A.
M D GeorgeDivision of Rheumatology, University of Pennsylvania, Philadelphia, PA, U.S.A.ORCID 0000-0002-0398-2308

Funding

Risk and impact of infection resulting from treatment with chronic glucocorticoids in patients with rheumatoid arthritisK23AR073931 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI GEORGE, MICHAEL D. · 2018 to 2022
$873k
Treatment of Dermatomyositis with Ajulemic Acid, a Non-Psychoactive CannabinoidR21AR066286 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI WERTH, VICTORIA P · 2014 to 2016
$387k
Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development)NIAMS NIH HHS K23 AR073931NIAMS NIH HHS R21 AR066286NIH HHS R21-AR066286Rheumatology Research Foundation Scientist Development Award
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAutoantibodiesFalse Negative ReactionsFemaleHumansLaboratoriesMaleMiddle AgedMyositisReagent Kits, DiagnosticRetrospective StudiesAutoantibodiesReagent Kits, Diagnostic

Identifiers

PMID31102270
PMCPMC6824930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.